CMS Finalizes Annual DMEPOS Accreditation Requirements for 2026

Introduction

CMS Annual DMEPOS Accreditation Updates 2026

Beginning January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will implement significant changes to how Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers are accredited, surveyed, and monitored.

Finalized under the CY 2026 Home Health Prospective Payment System (HHPPS) Final Rule, these changes replace the historical three-year reaccreditation cycle with a requirement for annual accreditation and resurvey. The updated framework reflects CMS’s continued focus on program integrity, consistent oversight, and ongoing verification of supplier compliance.

For Medicare-enrolled DMEPOS suppliers subject to accreditation, these changes represent a structural shift in how compliance must be managed on an ongoing basis.

Overview of CMS DME Accreditation Changes for 2026

CMS finalized multiple policy updates that collectively redefine how accreditation functions within the DMEPOS program. These requirements apply to suppliers that must maintain accreditation in order to bill Medicare.

CMS Annual DMEPOS Accreditation and Resurvey Requirement

Beginning in 2026, CMS will require DMEPOS suppliers to be resurveyed and reaccredited at least once every twelve (12) months. This replaces the prior requirement that accreditation surveys occur at least once every thirty-six (36) months.

CMS has clarified how the transition to annual accreditation will occur. Suppliers operating under an existing three-year accreditation cycle prior to the effective date will not be required to shorten that cycle. Instead, the annual reaccreditation requirement will begin once the supplier’s current accreditation term expires. From that point forward, reaccreditation must occur annually.

For suppliers receiving initial accreditation on or after January 1, 2026, the annual reaccreditation requirement will apply beginning one year after the initial accreditation effective date.

This annual requirement applies to each accredited location and is a central component of the DMEPOS accreditation requirements for 2026.

Unannounced Annual DME Accreditation Survey

CMS reaffirmed that DMEPOS accreditation surveys must continue to be conducted on an unannounced basis. Accrediting organizations are not permitted to provide advance notice of survey dates.

While unannounced surveys were already required prior to 2026, the shift to an annual survey cycle significantly increases their operational impact. Suppliers must now be prepared for an unannounced accreditation survey every year rather than once every three years.

Under this framework, compliance readiness must be maintained continuously across operational practices, documentation, training, and physical site requirements.

Elimination of Temporary Accreditation

Effective January 1, 2026, CMS is eliminating temporary accreditation for new DMEPOS locations. Previously, accrediting organizations were permitted to grant limited accreditation to certain newly operational locations prior to completing an onsite survey.

Under the revised policy, accrediting organizations must conduct a survey of a location before granting accreditation. New locations that intend to bill Medicare must complete the accreditation survey process prior to being accredited. No provisional or temporary accreditation pathway will be available.

This change directly affects suppliers planning to open new locations, acquire facilities, or restructure operations and should be incorporated into expansion and transaction timelines.

Ownership Changes and Re-Enrollment Risk

CMS also finalized provisions addressing changes in majority ownership. Under specific circumstances, a DMEPOS supplier that undergoes a change in majority ownership may be required to enroll as a new supplier rather than continue under an existing enrollment.

When a supplier is required to enroll as a new entity, it may also be subject to new accreditation and survey requirements. This creates potential exposure related to enrollment continuity and billing privileges if not evaluated in advance.

CMS outlined time-based conditions and exceptions related to ownership changes. Because these requirements are fact-specific, suppliers considering ownership transactions, restructuring, or acquisitions should assess the regulatory impact prior to execution.

Increased CMS Oversight of Accrediting Organizations

CMS finalized additional oversight requirements for CMS-approved accrediting organizations, including enhanced reporting, monitoring, and performance accountability expectations.

For suppliers, increased CMS oversight of accrediting organizations is expected to result in greater consistency in survey execution and enforcement of accreditation standards across accrediting bodies.

Overall, these changes aim to strengthen compliance integrity by improving transparency, reducing variability in accreditation outcomes, and ensuring that patient safety and quality-of-care benchmarks are applied uniformly across all CMS-recognized accrediting entities.

What This Means for DMEPOS Suppliers?

Collectively, the CMS accreditation changes reflect a shift toward more frequent and structured verification of compliance. Under the annual model, suppliers must demonstrate ongoing adherence to accreditation and quality standards rather than preparing for surveys on a multi-year cycle.

Because surveys are unannounced and conducted annually, suppliers should maintain continuous readiness across operational, documentation, training, and governance areas. Gaps that may have remained undetected for extended periods under a three-year cycle are more likely to be identified under the new framework.

The CMS annual DMEPOS accreditation requirement becomes an ongoing operational obligation directly tied to Medicare billing eligibility.

Alignment With CMS Supplier Standards DME

Accreditation remains closely linked to the CMS supplier standards DME codified in federal regulation. Suppliers must continue to meet all applicable supplier standards, including requirements related to licensure, physical location, hours of operation, complaint resolution, record retention, and business practices.

Accrediting organizations verify compliance with CMS quality standards during surveys, and CMS enrollment contractors rely on accreditation status when determining whether a supplier may bill Medicare. Suppliers must ensure that the products and services they bill are consistent with the scope of their accreditation.

Failure to maintain alignment between enrollment information, accreditation scope, and actual operations can result in claim denials, corrective action requirements, or enforcement actions.

DMEPOS Compliance Under an Annual Accreditation Model

The annual reaccreditation framework increases the importance of structured compliance governance. Policies, procedures, training records, and operational practices must remain current throughout the year rather than being updated solely in anticipation of surveys.

Because accrediting organizations may survey at any time within the accreditation period, suppliers benefit from treating compliance as an ongoing operational discipline rather than a periodic project.

 

This approach supports sustained adherence to DMEPOS compliance requirements under the revised CMS framework.

Why Choose QPI Healthcare Services?

The transition to annual, unannounced accreditation requires DMEPOS suppliers to maintain continuous compliance rather than preparing periodically for surveys. QPI Healthcare Services was built to support suppliers operating under this level of regulatory oversight.

Rather than treating accreditation as a one-time event, QPI helps suppliers establish structured, ongoing compliance aligned with CMS supplier standards and accrediting organization requirements. Through its proprietary Lavear HARP Light Technology, QPI provides centralized oversight of documentation, deadlines, and compliance indicators reviewed during accreditation surveys.

QPI’s compliance framework is accreditation-organization agnostic, supporting suppliers accredited through ACHC, The Joint Commission, CHAP, NABP, The Compliance Team, and other CMS-approved accrediting organizations. This approach supports consistent readiness under the annual accreditation model.

 

To discuss how continuous compliance oversight works in practice, you can schedule an accreditation readiness review with the QPI team.

Accreditation Organization Coverage

QPI Healthcare Services supports suppliers accredited by CMS approved accrediting organizations, including:

Support is structured to align supplier operations with both CMS requirements and accrediting organization standards.

Annual reaccreditation is now a permanent condition of participation for Medicare DMEPOS suppliers subject to accreditation. The CMS annual DMEPOS accreditation requirement increases survey frequency, eliminates temporary accreditation, and heightens the importance of continuous compliance.

Suppliers that rely on ad hoc preparation or manual tracking face increased operational and billing risk under the 2026 framework. Establishing structured, ongoing compliance practices is essential to maintaining accreditation and Medicare billing eligibility.

Worry About Next Steps?

Suppliers should evaluate their current accreditation timelines, ownership structure, and location plans to understand how the 2026 requirements apply. Early readiness assessments allow suppliers to identify gaps and address them before the annual cycle begins.

Contact Us

Let's Talk Compliance

FAQs About CMS Annual DMEPOS Accreditation Requirements (2026)

What is the timeline for implementing 2026 DME accreditation changes?

The annual DMEPOS accreditation requirements take effect on January 1, 2026, but current suppliers continue their existing 3-year cycle until it expires. New suppliers accredited on or after 1/1/2026 will be surveyed annually. Start preparing now, QPI Healthcare Services offers gap assessments in 2024-2025, policy updates by mid-2025, and mock surveys before year-end to ensure you’re ready.

 

Failing an annual survey can lead to corrective action timelines, possible accreditation impact, and Medicare billing interruptions if unresolved. With shorter turnaround between surveys, continuous compliance is critical. QPI’s real-time monitoring and audit preparation services help avoid deficiencies, while our crisis recovery support addresses issues quickly to prevent enrollment actions.

No single organization is best for all suppliers. Choose based on your services and size: ACHC for DME/pharmacy, CHAP for home health/hospice, Joint Commission for hospitals. QPI’s accreditation assessment service recommends the best fit and prepares you for annual unannounced surveys under the 2026 framework.

New DMEPOS startups after 1/1/2026 must achieve full accreditation before billing Medicare—temporary accreditation is eliminated. Startups need early licensure, PTAN enrollment, policy development, and staff training. QPI’s DME startup bootcamp streamlines this with surety bond setup, compliance system implementation, and survey readiness prep to avoid delays.